BIOMAT Database Logo BIOMAT Database Logo

The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production. 2000

J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Departments of Medicine and the Institute of Human Nutrition, Columbia University College of Physicians & Surgeons, New York, NY 10032, USA.

Apolipoprotein E (apoE) and lipoprotein lipase (LPL), key proteins in the regulation of lipoprotein metabolism, bind with high affinity to heparin and cell-surface heparan sulfate proteoglycan (HSPG). In the present study, we tested whether the expression of apoE or LPL would modulate proteoglycan (PG) metabolism in cells. Two apoE-expressing cells, macrophages and fibroblasts, and LPL-expressing Chinese hamster ovary (CHO) cells were used to study the effect of apoE and LPL on PG production. Cellular PGs were metabolically labeled with (35)[S]sulfate for 20 hours, and medium, pericellular PGs, and intracellular PGs were assessed. In all transfected cells, PG levels in the 3 pools increased 1.6- to 3-fold when compared with control cells. Initial PG production was assessed from the time of addition of radiolabeled sulfate; at 1 hour, there was no difference in PG synthesis by apoE-expressing cells when compared with control cells. After 1 hour, apoE-expressing cells had significantly greater production of PGs. Total production assessed with [(3)H]glucosamine was also increased. This was due to an increase in the length of the glycosaminoglycan chains. To assess whether the increase in PGs was due to a decrease in PG degradation, a pulse-chase experiment was performed. Loss of sulfate-labeled pericellular PGs was similar in apoE and control cells, but more labeled PGs appeared in the medium of the apoE-expressing cells. Addition of exogenous apoE and anti-human apoE antibody to both non-apoE-expressing and apoE-expressing cells did not alter PG production. Moreover, LPL addition did not alter cell-surface PG metabolism. These results show that enhanced gene expression of apoE and LPL increases cellular PG production. We postulate that such changes in vascular PGs can affect the atherogenic potential of arteries.

UI MeSH Term Description Entries
D008071 Lipoprotein Lipase An enzyme of the hydrolase class that catalyzes the reaction of triacylglycerol and water to yield diacylglycerol and a fatty acid anion. The enzyme hydrolyzes triacylglycerols in chylomicrons, very-low-density lipoproteins, low-density lipoproteins, and diacylglycerols. It occurs on capillary endothelial surfaces, especially in mammary, muscle, and adipose tissue. Genetic deficiency of the enzyme causes familial hyperlipoproteinemia Type I. (Dorland, 27th ed) EC 3.1.1.34. Heparin-Clearing Factor,Lipemia-Clearing Factor,Diacylglycerol Lipase,Diglyceride Lipase,Post-Heparin Lipase,Postheparin Lipase,Postheparin Lipoprotein Lipase,Factor, Heparin-Clearing,Factor, Lipemia-Clearing,Heparin Clearing Factor,Lipase, Diacylglycerol,Lipase, Diglyceride,Lipase, Lipoprotein,Lipase, Post-Heparin,Lipase, Postheparin,Lipase, Postheparin Lipoprotein,Lipemia Clearing Factor,Lipoprotein Lipase, Postheparin,Post Heparin Lipase
D011509 Proteoglycans Glycoproteins which have a very high polysaccharide content. Proteoglycan,Proteoglycan Type H
D011817 Rabbits A burrowing plant-eating mammal with hind limbs that are longer than its fore limbs. It belongs to the family Leporidae of the order Lagomorpha, and in contrast to hares, possesses 22 instead of 24 pairs of chromosomes. Belgian Hare,New Zealand Rabbit,New Zealand Rabbits,New Zealand White Rabbit,Rabbit,Rabbit, Domestic,Chinchilla Rabbits,NZW Rabbits,New Zealand White Rabbits,Oryctolagus cuniculus,Chinchilla Rabbit,Domestic Rabbit,Domestic Rabbits,Hare, Belgian,NZW Rabbit,Rabbit, Chinchilla,Rabbit, NZW,Rabbit, New Zealand,Rabbits, Chinchilla,Rabbits, Domestic,Rabbits, NZW,Rabbits, New Zealand,Zealand Rabbit, New,Zealand Rabbits, New,cuniculus, Oryctolagus
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D006025 Glycosaminoglycans Heteropolysaccharides which contain an N-acetylated hexosamine in a characteristic repeating disaccharide unit. The repeating structure of each disaccharide involves alternate 1,4- and 1,3-linkages consisting of either N-acetylglucosamine (see ACETYLGLUCOSAMINE) or N-acetylgalactosamine (see ACETYLGALACTOSAMINE). Glycosaminoglycan,Mucopolysaccharides
D006224 Cricetinae A subfamily in the family MURIDAE, comprising the hamsters. Four of the more common genera are Cricetus, CRICETULUS; MESOCRICETUS; and PHODOPUS. Cricetus,Hamsters,Hamster
D006493 Heparin A highly acidic mucopolysaccharide formed of equal parts of sulfated D-glucosamine and D-glucuronic acid with sulfaminic bridges. The molecular weight ranges from six to twenty thousand. Heparin occurs in and is obtained from liver, lung, mast cells, etc., of vertebrates. Its function is unknown, but it is used to prevent blood clotting in vivo and vitro, in the form of many different salts. Heparinic Acid,alpha-Heparin,Heparin Sodium,Liquaemin,Sodium Heparin,Unfractionated Heparin,Heparin, Sodium,Heparin, Unfractionated,alpha Heparin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001057 Apolipoproteins E A class of protein components which can be found in several lipoproteins including HIGH-DENSITY LIPOPROTEINS; VERY-LOW-DENSITY LIPOPROTEINS; and CHYLOMICRONS. Synthesized in most organs, Apo E is important in the global transport of lipids and cholesterol throughout the body. Apo E is also a ligand for LDL receptors (RECEPTORS, LDL) that mediates the binding, internalization, and catabolism of lipoprotein particles in cells. There are several allelic isoforms (such as E2, E3, and E4). Deficiency or defects in Apo E are causes of HYPERLIPOPROTEINEMIA TYPE III. Apo-E,Apo E,Apo E Isoproteins,ApoE,Apolipoprotein E Isoproteins,Apoprotein (E),Apoproteins E,Isoproteins, Apo E,Isoproteins, Apolipoprotein E

Related Publications

J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Apolipoprotein E and lipoprotein lipase co-ordinately enhance binding and uptake of chylomicrons by human hepatocytes.
November 1995, European journal of clinical investigation,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Inhibition of lipoprotein lipase by the receptor-binding domain of apolipoprotein E.
July 1989, FEBS letters,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Very-low-density lipoprotein binding to the apolipoprotein E receptor 2 is enhanced by lipoprotein lipase, and does not require apolipoprotein E.
April 2000, The Biochemical journal,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Modulation, by apolipoprotein E, of lipoprotein lipase activity.
May 1980, Biochemical and biophysical research communications,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Effect of heparin-induced lipolysis on the distribution of apolipoprotein e among lipoprotein subclasses. Studies with patients deficient in hepatic triglyceride lipase and lipoprotein lipase.
February 1985, The Journal of clinical investigation,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Lipoprotein lipase reduces secretion of apolipoprotein E from macrophages.
May 1997, The Journal of biological chemistry,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
[Heparin and lipoprotein lipase].
March 1962, El Dia medico,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Heparin binding to lipoprotein lipase and low density lipoproteins.
October 1985, FEBS letters,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Lipoprotein lipase-enhanced binding of human triglyceride-rich lipoproteins to heparan sulfate: modulation by apolipoprotein E and apolipoprotein C.
April 1996, Journal of lipid research,
J C Obunike, and S Pillarisetti, and L Paka, and Y Kako, and M J Butteri, and Y Y Ho, and W D Wagner, and N Yamada, and T Mazzone, and R J Deckelbaum, and I J Goldberg
Isolation of apolipoprotein-free lipoprotein lipase from human post-heparin plasma.
May 1971, Biochemical and biophysical research communications,
Copied contents to your clipboard!